Literature DB >> 16539081

Orphan drug policies: implications for the United States, Canada, and developing countries.

Richard Y Cheung1, Jillian C Cohen, Patricia Illingworth.   

Abstract

Mesh：

Year:  2004        PMID： 16539081

Source DB:  PubMed          Journal:  Health Law J        ISSN： 1192-8336


× No keyword cloud information.
  8 in total

Review 1.  Rare diseases, orphan drugs and their regulation: questions and misconceptions.

Authors:  Erik Tambuyzer
Journal:  Nat Rev Drug Discov       Date:  2010-11-09       Impact factor: 84.694

Review 2.  Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives.

Authors:  Peipei Song; Jianjun Gao; Yoshinori Inagaki; Norihiro Kokudo; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 3.  A human-on-a-chip approach to tackling rare diseases.

Authors:  Camilly P Pires de Mello; John Rumsey; Victoria Slaughter; James J Hickman
Journal:  Drug Discov Today       Date:  2019-08-11       Impact factor: 7.851

Review 4.  Unintended effects of orphan product designation for rare neurological diseases.

Authors:  Sinéad M Murphy; Araya Puwanant; Robert C Griggs
Journal:  Ann Neurol       Date:  2012-10       Impact factor: 10.422

Review 5.  Reprofiled drug targets ancient protozoans: drug discovery for parasitic diarrheal diseases.

Authors:  Anjan Debnath; Momar Ndao; Sharon L Reed
Journal:  Gut Microbes       Date:  2012-11-08

Review 6.  Regulatory environment for novel therapeutic development in mitochondrial diseases.

Authors:  Michio Hirano; Andres Berardo; Emanuele Barca; Valentina Emmanuele; Catarina Quinzii; Camilla V Simpson; Kristin Engelstad; Xiomara Q Rosales; John L P Thompson
Journal:  J Inherit Metab Dis       Date:  2021-01-04       Impact factor: 4.750

7.  Targeting proinflammatory cytokines ameliorates calcifying phenotype conversion of vascular progenitors under uremic conditions in vitro.

Authors:  Björn Hegner; Theres Schaub; Daniel Janke; Daniel Zickler; Claudia Lange; Matthias Girndt; Joachim Jankowski; Ralf Schindler; Duska Dragun
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

8.  The urgent need to empower rare disease organizations in China: an interview-based study.

Authors:  Xuefeng Li; Zijuan Lu; Jianyong Zhang; Xiangyu Zhang; Shu Zhang; Jincheng Zhou; Bingzhe Li; Li Ou
Journal:  Orphanet J Rare Dis       Date:  2020-10-12       Impact factor: 4.123
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.